PANCREAS CANCER
Clinical trials for PANCREAS CANCER explained in plain language.
Never miss a new study
Get alerted when new PANCREAS CANCER trials appear
Sign up with your email to follow new studies for PANCREAS CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early cancer drug trial halted before key testing phase
Disease control TerminatedThis early-stage study tested a new oral cancer drug called NUV-868, both alone and combined with existing medications (olaparib or enzalutamide), in adults with advanced solid tumors. The trial aimed to find safe doses and see if these treatments could help control cancers that …
Matched conditions: PANCREAS CANCER
Phase: PHASE1 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Early trial halted after testing new drug combo for deadly cancer
Disease control TerminatedThis early-stage study tested whether adding the experimental drug NIS793 to standard chemotherapy (FOLFIRINOX) could help control metastatic pancreatic cancer. The trial aimed to find a safe dose and see if the combination improved tumor removal rates through surgery. The study …
Matched conditions: PANCREAS CANCER
Phase: PHASE1 • Sponsor: Colin D. Weekes, M.D., PhD • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC